Firefly Neuroscience (NASDAQ:AIFF) Posts Quarterly Earnings Results

Firefly Neuroscience (NASDAQ:AIFF) announced its quarterly earnings results on Tuesday. The company reported ($0.13) earnings per share for the quarter, FiscalAI reports. The company had revenue of $0.49 million during the quarter. Firefly Neuroscience had a negative net margin of 1,740.98% and a negative return on equity of 229.99%.

Firefly Neuroscience Price Performance

AIFF traded up $0.03 during midday trading on Wednesday, reaching $1.83. 135,508 shares of the company’s stock traded hands, compared to its average volume of 7,196,577. Firefly Neuroscience has a 52 week low of $0.62 and a 52 week high of $3.77. The firm has a fifty day moving average of $1.91 and a two-hundred day moving average of $1.49. The stock has a market capitalization of $26.99 million, a price-to-earnings ratio of -1.01 and a beta of 0.60.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on AIFF shares. Weiss Ratings cut Firefly Neuroscience from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Monday, May 4th. Wall Street Zen cut Firefly Neuroscience from a “hold” rating to a “sell” rating in a research report on Saturday, May 2nd. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has a consensus rating of “Sell”.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the company. Jane Street Group LLC bought a new position in shares of Firefly Neuroscience in the 4th quarter worth approximately $53,000. Vanguard Group Inc. raised its position in shares of Firefly Neuroscience by 393.3% in the 3rd quarter. Vanguard Group Inc. now owns 503,071 shares of the company’s stock worth $1,464,000 after acquiring an additional 401,085 shares in the last quarter. Savvy Advisors Inc. bought a new position in shares of Firefly Neuroscience in the 3rd quarter worth approximately $63,000. Finally, Geode Capital Management LLC increased its position in Firefly Neuroscience by 92.9% during the 2nd quarter. Geode Capital Management LLC now owns 120,604 shares of the company’s stock valued at $341,000 after buying an additional 58,067 shares in the last quarter. Institutional investors own 4.96% of the company’s stock.

Firefly Neuroscience Company Profile

Firefly Neuroscience is a clinical?stage neurotechnology company focused on developing digital biomarkers and cognitive assessment tools for the early detection and monitoring of neurological disorders. The company’s platform combines mobile applications, sensor technology and advanced analytics to capture objective brain function data outside of traditional clinical settings. By providing real?world cognitive and physiological measurements, Firefly aims to improve diagnosis, track disease progression and support therapeutic development.

The company’s flagship offering is a smartphone?based cognitive assessment app that guides users through a series of interactive tasks designed to measure attention, memory, processing speed and executive function.